Search

Cutivate

Cutivate

fluticasone

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Fluticasone propionate
Indications/Uses
Adults & childn ≥3 mth: Atopic, infantile & discoid eczemas, prurigo nodularis, psoriasis (excluding widespread plaque psoriasis), neurodermatoses including lichen simplex & planus, seborrheic dermatitis, contact sensitivity reactions, discoid lupus erythematosus. Adjunct to systemic steroid therapy in generalised erythroderma. Reduce risk of chronic recurrent atopic eczema relapse once acute episode has been treated effectively. Adults & childn ≥1 yr: Insect bite reactions, prickly heat.
Click to view Cutivate detailed prescribing information
Dosage/Direction for Use
Apply thinly to affected area once or bd for up to 4 wk. Patient who frequently relapse Reduce to once daily twice wkly.
Click to view Cutivate detailed prescribing information
Overdosage
View Cutivate overdosage for action to be taken in the event of an overdose.
Contraindications
Untreated cutaneous infection, rosacea, acne vulgaris, perioral dermatitis, perianal & genital pruritus, pruritus w/o inflammation. Dermatoses in infants <3 mth including dermatitis & nappy rash.
Click to view Cutivate detailed prescribing information
Special Precautions
Hypersensitivity to corticosteroids. Cushing's syndrome & reversible hypothalmic-pituitary-adrenal axis suppression. Increased risk of systemic effects. Concomitant infection. Psoriasis; chronic leg ulcers; visual disturbances. Allergic sensitisation or irritation due to formaldehyde. Use w/ occlusive dressings. Avoid contact w/ face & eyes. Avoid abrupt w/drawal. Renal or hepatic impairment. Pregnancy & lactation. Avoid long-term continuous therapy in infants & childn <12 yr. Paed patients <3 mth. Elderly.
Click to view Cutivate detailed prescribing information
Drug Interactions
Inhibited metabolism by CYP3A4 inhibitors eg, ritonavir, itraconazole.
Click to view Cutivate detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Cutivate detailed prescribing information
Storage
View Cutivate storage conditions for details to ensure optimal shelf-life.
Description
View Cutivate description for details of the chemical structure and excipients (inactive components).
Action
View Cutivate mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Topical Corticosteroids
ATC Classification
D07AC17 - fluticasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Cutivate cream 0.05%
Packing/Price
15 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in